INVO FERTILITY INC (IVF)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$0.98+0.16%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · IVF
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||
| Revenues | 7.5 | 6.8 | 6.5 | 3.0 | 0.8 | 4.2 | 1.0 | 1.5 | 0.5 | 0.3 | 0.1 | 0.0 |
| Total Revenues | 7.5 | 6.8 | 6.5 | 3.0 | — | — | 1.0 | 1.5 | 0.5 | 0.3 | 0.1 | 0.0 |
| Cost of Revenues | — | 0.0 | 3.7 | 2.0 | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | — | — | — |
| Gross Profit | — | — | — | — | 0.5 | 4.0 | 0.9 | 1.3 | 0.4 | 0.2 | 0.0 | 0.0 |
| Operating Expenses & Income | ||||||||||||
| Selling, General & Admin | 8.0 | 7.7 | 9.1 | 7.5 | 10.0 | 9.0 | 6.1 | 3.1 | 3.0 | 0.9 | 2.1 | 0.6 |
| R&D Expenses | — | — | 0.5 | 0.2 | 0.5 | 0.2 | 0.4 | — | — | — | — | — |
| Operating Income | (5.9) | (7.2) | (8.1) | (6.8) | (10.6) | (5.2) | (5.5) | (1.8) | (2.6) | (0.6) | (2.1) | (0.6) |
| Earnings from Continuing Operations | ||||||||||||
| Interest Expense | — | 1.3 | 1.1 | 0.9 | 0.1 | 1.3 | 2.8 | 0.4 | 0.4 | 0.0 | 0.0 | 0.0 |
| Interest & Investment Income | — | — | — | — | — | — | 0.0 | — | — | — | — | — |
| Net Interest Expenses | — | — | — | — | — | — | 2.8 | — | — | — | — | — |
| Other Non-Operating Income / Expenses | (0.4) | 1.8 | (1.0) | (1.2) | (0.3) | (1.4) | (2.8) | (0.4) | (0.4) | — | — | — |
| EBT, Incl. Unusual Items | — | (5.5) | (9.1) | (8.0) | (10.9) | (6.7) | (8.3) | (2.2) | (3.1) | (0.7) | (2.1) | (5.0) |
| Income Tax Expense | — | (0.2) | (0.0) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Earnings from Continuing Operations | (6.2) | (5.3) | — | — | — | — | — | — | — | — | — | — |
| Net Income | ||||||||||||
| Net Income | 40.4 | (23.3) | (9.1) | 8.0 | (10.9) | (6.7) | (8.3) | (2.2) | (3.1) | (0.7) | (2.1) | (5.0) |
| Per Share | ||||||||||||
| Basic EPS | 19.21 | (214.64) | (30.19) | (67.37) | (17.97) | (0.63) | (1.52) | (0.45) | (0.02) | 0.00 | (0.02) | (0.04) |
| Diluted EPS | 15.60 | (214.64) | (30.19) | (67.37) | (17.97) | (0.63) | (1.52) | (0.45) | (0.02) | 0.00 | (0.02) | (0.04) |
| Revenue per Share | 2.91 | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 2.1 | 0.1 | 0.3 | 0.1 | 0.6 | 10.6 | 5.5 | 4.9 | 147.3 | 141.3 | 139.2 | 128.6 |
| Diluted Weighted Avg Shares | 2.6 | 0.1 | 0.3 | 0.1 | 0.6 | 10.6 | 5.5 | 4.9 | 147.3 | 141.3 | 139.2 | 128.6 |
| Supplemental | ||||||||||||
| EBITDA | — | (6.6) | (7.2) | (6.6) | (10.5) | (5.2) | (5.5) | (1.8) | (2.6) | (0.6) | (2.1) | (0.6) |
| EBIT | (5.9) | (7.2) | (8.1) | (6.8) | (10.6) | (5.2) | (5.5) | (1.8) | (2.6) | (0.6) | (2.1) | (0.6) |
| Effective Tax Rate | — | — | — | -0.3% | -0.0% | -0.1% | -0.0% | -0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.